InsiderTrades

Form 4 for MET MetLife

Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-19 · accession 0001770295-22-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-08-23 2022-08-19 MET DEBEL MARLENE EVP, CRO M - OptEx $31.15 +5,513 59.4K +10% +$171.7K
D 2022-08-23 2022-08-19 MET DEBEL MARLENE EVP, CRO S - Sale+OE $67.60 -4,060 55.3K -7% -$274.5K
D 2022-08-23 2022-08-19 MET DEBEL MARLENE EVP, CRO M - OptEx $0.00 -5,513 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-08-19 M A 5,513 $31.15 59,359 D — —
2 Common Common Stock 2022-08-19 S D 4,060 $67.60 55,299 D — — (F1) The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 19, 2022 and related tax obligations and fees.
3 Derivative Employee Stock Options (right to buy) 2022-08-19 M D 5,513 $0.00 0 D $31.15 · — to 2023-02-25 5,513 Common Stock (F2) The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016.